Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, (a) how many and (b) what proportion of children aged under five in (i) the Nottingham North constituency, (ii) Nottingham city and (iii) the East Midlands received milk through the Nursery Milk Scheme in the last year for which figures are available.
Answered by Baroness Blackwood of North Oxford
These figures are not collected centrally.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps the Government has taken to comply with EU law since the launch of infringement proceedings against the UK under Article 258 of the Treaty on the Functioning of the EU on 11 June 2011, with respect to the entitlement to treatment by the NHS of EU citizens resident in the UK.
Answered by Philip Dunne
In terms of the infringement proceedings referred to, the United Kingdom Government has corresponded with the Commission and we are satisfied that we are compliant with European Union law in that respect.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 14 November 2016 to Question 52787, when the Cardiovascular Disease collaborative group commenced its work; and if he will set out is plan of work.
Answered by David Mowat
The Cardiovascular Disease (CVD) Collaborative was established in 2013, when NHS England took up its statutory roles. Initially its purpose was to monitor progress following the Department’s publication of the CVD Outcomes Strategy (2013).
Subsequently, NHS England's priorities, and those of other arm’s length bodies such as Public Health England, were focused around the Five Year Forward View, and so in 2016 they discussed with stakeholders how the Collaborative could be reconfigured to reflect this shift in focus. The Five Year Forward View has many objectives which are relevant to CVD and the CVD Collaborative is intended to support these.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will make an assessment of the achievements of the (a) Cardiovascular disease (CVD) outcomes strategy and (b) CVD expert forum since their establishment.
Answered by David Mowat
No assessment has been made of the achievements of the Cardiovascular Disease (CVD) Outcomes Strategy or the CVD collaborative group.
The CVD collaborative group is still in the early days of establishment. Its principle purpose is to bring together relevant stakeholders in the field of CVD and to provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined. The group’s overarching objective is to improve health outcomes for people with or at risk of CVD, including stroke.
Membership of the group comprises of representatives from NHS England including the relevant National Clinical Directors; Public Health England; Diabetes UK; British Heart Foundation; Heart-UK; British Kidney Health Association; Stroke Association and the Local Government Association.
The group aims to meet three times per year.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 11 October 2016 to Question 46460, who the members of the Cardiovascular Disease expert forum are; and how regularly that forum meets.
Answered by David Mowat
No assessment has been made of the achievements of the Cardiovascular Disease (CVD) Outcomes Strategy or the CVD collaborative group.
The CVD collaborative group is still in the early days of establishment. Its principle purpose is to bring together relevant stakeholders in the field of CVD and to provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined. The group’s overarching objective is to improve health outcomes for people with or at risk of CVD, including stroke.
Membership of the group comprises of representatives from NHS England including the relevant National Clinical Directors; Public Health England; Diabetes UK; British Heart Foundation; Heart-UK; British Kidney Health Association; Stroke Association and the Local Government Association.
The group aims to meet three times per year.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 13 July 2016 to Question 42224, what the remit of the Cardiovascular Disease collaborative group is; and how regularly that group meets.
Answered by David Mowat
No assessment has been made of the achievements of the Cardiovascular Disease (CVD) Outcomes Strategy or the CVD collaborative group.
The CVD collaborative group is still in the early days of establishment. Its principle purpose is to bring together relevant stakeholders in the field of CVD and to provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined. The group’s overarching objective is to improve health outcomes for people with or at risk of CVD, including stroke.
Membership of the group comprises of representatives from NHS England including the relevant National Clinical Directors; Public Health England; Diabetes UK; British Heart Foundation; Heart-UK; British Kidney Health Association; Stroke Association and the Local Government Association.
The group aims to meet three times per year.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 11 October 2016 to Question 46460, what the stroke-specific aims and objectives of the Cardiovascular Disease expert forum are.
Answered by David Mowat
No assessment has been made of the achievements of the Cardiovascular Disease (CVD) Outcomes Strategy or the CVD collaborative group.
The CVD collaborative group is still in the early days of establishment. Its principle purpose is to bring together relevant stakeholders in the field of CVD and to provide a forum where relevant work being undertaken in this area and potential new initiatives can be discussed and responsibilities for action determined. The group’s overarching objective is to improve health outcomes for people with or at risk of CVD, including stroke.
Membership of the group comprises of representatives from NHS England including the relevant National Clinical Directors; Public Health England; Diabetes UK; British Heart Foundation; Heart-UK; British Kidney Health Association; Stroke Association and the Local Government Association.
The group aims to meet three times per year.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many tooth restorations using dental amalgam were carried out on the NHS in each of the last 10 years.
Answered by David Mowat
Information is not collected centrally on the number of restorations carried out on the National Health Service using dental amalgam.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will estimate the annual cost to the public purse of (a) extending free dental check-ups to people aged 60 and over and (b) exempting people aged over 60 from all dental charges.
Answered by David Mowat
The table below shows the estimated cost of extending exemption to National Health Service dental charges for paying patients under the age of 21, age 60 and over and for examinations only for patients aged 60 and over.
Age Group | Estimated Cost |
People aged 18-21 | £15.7 million |
People aged 60 and over | £329.2 million |
People aged 60 and over (for check-ups only) | £25.1 million |
This data is based on FP17s submitted to the NHS Business Services Authority for general dentistry courses of treatment completed between April 2015 and March 2016. It shows the amount of patient revenue, based on 2016/17 charge levels, which would be foregone should the currently fee paying groups be made exempt.
Dentists are required to submit a form called an FP17 for every course of NHS dental treatment they provide. The figures assume no increase in the number of patients currently accessing NHS dental care, in reality additional patients may seek NHS treatment if they were to become exempt.
Asked by: Graham Allen (Labour - Nottingham North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will estimate the annual cost to the public purse of extending free dental treatment to people under the age of 21.
Answered by David Mowat
The table below shows the estimated cost of extending exemption to National Health Service dental charges for paying patients under the age of 21, age 60 and over and for examinations only for patients aged 60 and over.
Age Group | Estimated Cost |
People aged 18-21 | £15.7 million |
People aged 60 and over | £329.2 million |
People aged 60 and over (for check-ups only) | £25.1 million |
This data is based on FP17s submitted to the NHS Business Services Authority for general dentistry courses of treatment completed between April 2015 and March 2016. It shows the amount of patient revenue, based on 2016/17 charge levels, which would be foregone should the currently fee paying groups be made exempt.
Dentists are required to submit a form called an FP17 for every course of NHS dental treatment they provide. The figures assume no increase in the number of patients currently accessing NHS dental care, in reality additional patients may seek NHS treatment if they were to become exempt.